Literature DB >> 15136223

Recommended reporting format for flow cytometry diagnosis of acute leukemia.

Luigi Del Vecchio1, Bruno Brando, Francesco Lanza, Claudio Ortolani, Giovanni Pizzolo, Gianpietro Semenzato, Giuseppe Basso.   

Abstract

Although flow cytometry is increasingly used as a tool to diagnose hematologic malignancies, the reporting format of acute leukemia immunodiagnosis is still imprecise and sometimes vague, often reflecting old guidelines. Thus, the purpose of the present work was to make the reporting format for the immunological diagnosis of acute leukaemia easy and clear to understand. This work represents part of a more articulated series of technical guidelines that the Italian Society for Cytometry (GIC) is currently processing. Thirteen separate recommendations, covering all aspects of an acute leukemia cytometry report, are listed. According to our suggestions, the report must contain clear statements about: 1. demographic identification of patient; 2. identification of the hospital or division sending the sample; 3. type of specimen (bone marrow aspirate, peripheral blood, other biological fluids); 4. timing of observation (first diagnosis or follow-up); 5. diagnostic hypothesis made by the sender; 6. list of antigens and type of immunofluorescence analysis carried out; 7. absolute number of cells in the sample; 8. quality of the sample, in terms of viability; 9. general description of the gating procedure; 10. immunophenotype of blast cells; 11. description of cells surrounding blasts; 12. diagnostic conclusions; 13. definition of an antigen panel (when applicable) for the detection of minimal residual disease. As an example of a final report we present a case of acute myeloid leukaemia with t(8;21) translocation; in filling this report, we followed all the 13 points of the checklist described in the paper.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136223

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  4 in total

1.  Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.

Authors:  Enrica Morra; Giovanni Barosi; Alberto Bosi; Felicetto Ferrara; Franco Locatelli; Monia Marchetti; Giovanni Martinelli; Cristina Mecucci; Marco Vignetti; Sante Tura
Journal:  Haematologica       Date:  2008-11-10       Impact factor: 9.941

2.  Extended flow cytometry characterization of normal bone marrow progenitor cells by simultaneous detection of aldehyde dehydrogenase and early hematopoietic antigens: implication for erythroid differentiation studies.

Authors:  Peppino Mirabelli; Rosa Di Noto; Catia Lo Pardo; Paolo Morabito; Giovanna Abate; Marisa Gorrese; Maddalena Raia; Caterina Pascariello; Giulia Scalia; Marica Gemei; Elisabetta Mariotti; Luigi Del Vecchio
Journal:  BMC Physiol       Date:  2008-05-29

3.  Clinical Laboratories - Production Factories or Specialized Diagnostic Centers.

Authors:  János Kappelmayer; Judit Tóth
Journal:  EJIFCC       Date:  2016-04-20

4.  Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis.

Authors:  Ying-Jun Chang; Yu Wang; Yan-Rong Liu; Lan-Ping Xu; Xiao-Hui Zhang; Huan Chen; Yu-Hong Chen; Feng-Rong Wang; Wei Han; Yu-Qian Sun; Chen-Hua Yan; Fei-Fei Tang; Xiao-Dong Mo; Kai-Yan Liu; Xiao-Jun Huang
Journal:  J Hematol Oncol       Date:  2017-07-04       Impact factor: 17.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.